Trials / Withdrawn
WithdrawnNCT02551627
A Study to Investigate the Impact of a Multiple Micronutrient (MMN) Beverage Powder on Vaccine Response in School Children
Impact of a Multiple Micronutrient (MMN) Beverage Powder on Vaccine Response in School Children (7-10yrs; Inclusive) in Bangladesh: a Randomised, Double Blind Controlled Trial
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 7 Years – 10 Years
- Healthy volunteers
- Accepted
Summary
This will be a double blind, two-arm, parallel-group, stratified for gender, randomised, controlled study in participants aged 7-10 years (yrs). The aim of the study is to test the hypothesis that MMN fortified beverage may help improve immunity outcomes as assessed through vaccine response in 7-10 yrs old school participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Test Product | MMN fortified beverage powder. |
| DIETARY_SUPPLEMENT | Control | Isocaloric beverage powder without micronutrient fortification. |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2017-10-01
- Completion
- 2017-10-01
- First posted
- 2015-09-16
- Last updated
- 2017-12-20
Source: ClinicalTrials.gov record NCT02551627. Inclusion in this directory is not an endorsement.